# Johnson & Johnson (JNJ) — Q3-2013 Earnings Results

**Report date:** 2013-10-15 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2013

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Reaction Not Available

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.36 | N/A | +3.42% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting a commitment to operational improvements. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on improving operational efficiency.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

This earnings report shows that Johnson & Johnson managed to exceed EPS expectations, indicating solid performance in this area. However, the lack of revenue data and guidance leaves some uncertainty about future growth. The stock reaction was not available, making it difficult to gauge investor sentiment immediately following the report.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2013_